The Fund aims to provide long-term growth.
Name | % Net Assets |
---|---|
Glaxosmithkline | 5.1% |
Vodafone | 4.4% |
BG Grp | 4.4% |
Scottish & Southern | 4.1% |
Imperial Tobacco Grp | 3.9% |
BP | 3.0% |
Legal & General Grp | 2.9% |
Velti | 2.9% |
RBS Grp | 2.6% |
Barclays | 2.5% |
Key | % Net Assets |
---|---|
Glaxosmithkline | 5.1% |
Vodafone | 4.4% |
BG Grp | 4.4% |
Scottish & Southern | 4.1% |
Other | 82% |
Date | 02-Oct-2009 |
---|---|
NAV | 44.68p |
Currency | GBP |
Change | 0.070p |
% | 0.16% |
YTD change | 44.68p |
YTD % | n/a |
Fund Inception | 31/12/2005 |
---|---|
Fund Manager | Hilary Aldridge |
TER | - |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.13 |
You are here: research